Results 141 to 150 of about 1,086,070 (250)

Modelling tuberculosis in areas of high HIV prevalence

, 2006
We describe a discrete event simulation model of tuberculosis (TB) and HIV disease, parameterized to describe the dual epidemics in Harare, Zimbabwe. TB and HIV are the leading causes of death from infectious disease among adults worldwide and the number
Hughe, Georgina R., Corbett, Elizabeth L., Currie, C.S.M., Elizabeth Corbett, Christine Currie, Georgina Hughes   +5 more
core   +1 more source

Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study

, 2017
Abdulhalik Workicho, Wondwosen Kassahun, Fessahaye Alemseged Department of Epidemiology, College of Health Sciences, Jimma University, Jimma, Ethiopia Background: Multidrug-resistant tuberculosis (MDR-TB) did not receive major attention until ...
Workicho A, Kassahun W, Alemseged F
core  

Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China

, 2019
Yang Li,1,* Fei Wang,2,* Limin Wu,3 Min Zhu,4 Guiqing He,5 Xinchang Chen,1 Feng Sun,1 Qihui Liu,1 Xiaomeng Wang,2 Wenhong Zhang1 1Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200032, China; 2Zhejiang Provincial Center ...
Zhang W, Zhu M, Li Y, Wu L, He G, Wang F, Liu Q, Sun F, Chen X, Wang X   +9 more
core  

[The long term (9-year) survival of multidrug-resistant tuberculosis patients compared to non-multidrug-resistant tuberculosis patients in Henan province].

, 2013
[The long term (9-year) survival of multidrug-resistant tuberculosis patients compared to non-multidrug-resistant tuberculosis patients in Henan province]
G Hall (3596234), A Sleigh (13383024), XA Zhen (15839027), GJ Wang (15839024), Hassan Vally (13074096), YN Sun (15839021), D Harley (13383021), ZF Liu (14594543)   +7 more
core  

Point of care tests for tuberculosis (TB) : economic analysis report [PDF]

A number of clinical/disease areas have been prioritised by the TSB and DH for the DIIA Innovation Platform. To support commissioning of technology developments in the area of tuberculosis detection in humans, a scoping review has been undertaken to help
Szczepura, Ala, Osipenko, Leeza
core  

Treatment of multidrug-resistant tuberculosis with bedaquiline, pretomanid, linezolid, and moxifloxacin following near-total gastrectomy. [PDF]

ASM Case Rep
Weheba I, Brode SK, Richard-Greenblatt M, Sabur NF.   +3 more
europepmc   +1 more source

Global Burden of Tuberculosis and Drug-Resistant Subtypes Among Women of Childbearing Age from 1990 to 2021, with Projections to 2030. [PDF]

Int J Womens Health
Chen J, Peng X, Zheng Y, Chen R.
europepmc   +1 more source

High prevalence of resistance to first-line drugs and multidrug resistance in patients with tuberculosis and type 2 diabetes mellitus at a referral hospital in Peru. [PDF]

PLoS One
Barboza-Panaifo S, Erazo-Cárdenas I, Chapoñan-Agip NV, Tenorio-Quispe A, Yovera-Aldana M.   +4 more
europepmc   +1 more source

Multidrug-resistant tuberculosis: pharmacokinetic and pharmacodynamic science [PDF]

The Lancet Infectious Diseases, 2017
Alffenaar, Jan-Willem C., Migliori, Giovanni Battista, Gumbo, Tawanda   +2 more
openaire   +2 more sources

XDR TB [PDF]

Extensively drug resistant TB (XDR TB) is a rare type of multidrug-resistant tuberculosis (MDR TB) that is resistant to isoniazid and rifampin, plus any fluoroquinolone and at least one of three injectable second-line drugs (i.e., amikacin, kanamycin, or

core